GBA1 and Parkinson disease: A recent study reported higher levels of GluCer in the CSF in conjunction with a decrease in blood GCase activity in GBA‐PD compared with idiopathic PD, but the differences were observed primarily in those with severe GBA mutations (eg, L444P), but not the mild GBA mutation, N370S11 (GluSph was not assayed in this study).